Diabetes Treatment Denied in California: Appeal Guide

California is home to over 3.2 million adults living with diabetes, making it one of the most diabetes-affected states in the country. Despite robust state consumer protections, insurance denials for diabetes-related treatments remain frustratingly common. If your insurer has denied coverage for insulin, a continuous glucose monitor (CGM), an insulin pump, or medications like Ozempic or Mounjaro, you have meaningful rights under California law — and strong grounds to appeal.

The California Insurance Landscape for Diabetes

California's largest health insurers include Anthem Blue Cross of California, Kaiser Permanente, Health Net, Blue Shield of California, and a large Covered California marketplace. Employer-sponsored plans are common across the state's tech, entertainment, and agriculture sectors.

California has enacted some of the strongest diabetes-related insurance mandates in the nation. Under the California Health & Safety Code and Insurance Code, fully insured plans are required to cover:

• Insulin and diabetes medications without unreasonable Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization delays
• Blood glucose monitors and test strips
• Diabetes self-management education (DSME)
• Medical nutrition therapy

California's insulin cost-cap law limits out-of-pocket costs for insulin to $35 per 30-day supply for insured patients on state-regulated plans. If you are paying more than this, contact your insurer immediately.

Medicaid (Medi-Cal) and Diabetes Coverage

California's Medicaid program, Medi-Cal, provides diabetes coverage to millions of low-income Californians. Medi-Cal covers insulin, oral diabetes medications, blood glucose monitoring supplies, and CGMs for eligible enrollees. However, Medi-Cal managed care plans frequently impose prior authorization requirements that delay or block access to newer technologies like CGMs and GLP-1 receptor agonists.

If you are on Medi-Cal and your CGM or GLP-1 drug was denied, you have the right to request a State Fair Hearing through the California Department of Health Care Services (DHCS). This is a powerful tool that many patients overlook.

CGM Coverage in California

California passed legislation requiring state-regulated health insurance plans to cover continuous glucose monitors without undue cost-sharing barriers. CGMs like the Dexcom G7 and Abbott FreeStyle Libre are now standard of care for both Type 1 and Type 2 diabetes patients on insulin. Common denial reasons include:

• "Not medically necessary" for Type 2 patients
• Claiming the patient does not test frequently enough
• Prior authorization not approved because documentation was incomplete

To fight a CGM denial, your physician must document that the device improves glycemic control and reduces hypoglycemia risk. The American Diabetes Association's Standards of Care explicitly recommend CGM for all insulin-using patients.

Common Insurance Denials in California

GLP-1 Drugs (Ozempic, Mounjaro, Wegovy): Insurers including Anthem and Health Net frequently require step therapy — forcing patients to try and fail cheaper medications before approving GLP-1 agonists. California law allows insurers to impose step therapy, but also requires a step therapy exception process if the standard treatment would cause harm or has already failed.

Insulin Pumps: Denied for "not meeting medical criteria," often requiring documented failure of multiple daily injections (MDI) first.

Specialist Visits (Endocrinologist): Denied for out-of-network providers or requiring a referral that primary care physicians were slow to provide.

Jardiance and SGLT-2 inhibitors: Denied due to formulary placement or prior authorization requirements.

How to Appeal a Diabetes Denial in California

1. Request the EOB)" class="auto-link">Explanation of Benefits (EOB) and the insurer's medical necessity criteria for the denied item.
2. Get a letter of medical necessity from your physician that directly cites the ADA Standards of Care (updated annually) and your specific clinical history.
3. File an internal appeal within your insurer's deadline — usually 180 days from the denial notice.
4. Request an Independent Medical Review (IMR) through the California Department of Managed Health Care (DMHC) if the internal appeal fails. California's IMR process is free, fast (typically resolved within 30 days), and statistically favorable for patients — over 40% of IMR decisions overturn the insurer's denial.
5. File a complaint with the DMHC Help Center at 1-888-466-2219 or online at dmhc.ca.gov.

For plans regulated by the California Department of Insurance (CDI) rather than DMHC (typically indemnity plans), contact CDI at 1-800-927-4357.

State Insurance Department Contact

California Department of Managed Health Care (DMHC)

• Phone: 1-888-466-2219
• Website: dmhc.ca.gov

California Department of Insurance (CDI)

• Phone: 1-800-927-4357
• Website: insurance.ca.gov

Additional Resources

The American Diabetes Association (diabetes.org) provides advocacy resources, denial appeal templates, and a legal advocacy hotline. Their California office is particularly active in supporting patients navigating Medi-Cal and Covered California disputes.

Do not accept a denial as final. California law gives you multiple avenues — internal appeal, IMR, and state complaint — and the timeline to use them is manageable. Start with a strong letter of medical necessity and escalate if needed.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?